Modern Action logo
IssuesBillsBriefing
Donate
Donate
Modern Action

Navigation

Menu

01HomeFront page→02IssuesActive issue pages→03BillsLegislation index→04BriefingDaily context→05DonateSupport the work→

Account

Sign In→Get Started→
Modern Action

Find the bills behind the news, understand what Congress can do, and contact your representatives with a specific message.

Platform

  • Contact Congress
  • Write to Congress
  • Browse Bills
  • Track Bills

Resources

  • Find My Representatives
  • Contact My Representatives
  • How to Contact Representatives
  • Does Contacting Congress Work?

Support

  • Contact Us
  • Accessibility

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Accessibility

Stay informed about legislation

Get weekly updates on important bills and how to take action.

© 2026 Modern Action. All rights reserved.

Made with ❤️ for democracy
All systems operational

Contact Congress about S. 526: Pharmacy Benefit Manager Transparency Act of 2025

PBMs would face new limits on hidden drug pricing, clawbacks, and some payment cuts to pharmacies. They would have to file yearly reports, and the Federal Trade Commission could impose steep penalties. Workers and contractors who report violations would get strong legal protection.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Pharmacy Benefit Manager Transparency Act of 2025 is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Commerce, Science, and Transportation.

Latest action on S. 526: Read twice and referred to the Committee on Commerce, Science, and Transportation.

Who this affects: This bill mainly affects PBMs first, because it changes how they can handle money, report data, and respond to investigations. Pharmacies, especially independent pharmacies, could also be affected because the bill limits some clawbacks and payment cuts. Health plans, drug makers, regulators, and workers inside these companies would also be pulled in through new reporting, enforcement, and whistleblower rules. Patients could feel the effects later through drug access, pharmacy options, premiums, or out-of-pocket costs, but the bill does not spell out exactly how those prices would change.

Why this matters: This matters because PBM business practices can shape what drugs people can get, what pharmacies stay open, and how much money moves through the prescription drug system. The bill tries to pull hidden pricing and fee practices into the open and give regulators stronger tools to act. It could help lawmakers and payors understand where money goes, but the real effect on premiums, copays, and drug access would still depend on how PBMs, pharmacies, health plans, and drug makers respond.

Key provisions in S. 526

  • PBMs could not keep hidden profit from the gap between what they bill health plans and what they pay pharmacies. They could do so only if they pass through 100% of price concessions and fully disclose costs, prices, fees, and rebates.
  • PBMs could not take money back from pharmacies or cut payments after a claim in most cases. They could do it only in limited situations, such as fraud, a contract mismatch, or when the pharmacy did not provide the service.
  • PBMs could not raise pharmacy fees or cut pharmacy payments just to make up for federal reimbursement changes in federally funded health plans. They could do that only if they meet the bill's pass-through and disclosure rules.
  • PBMs could face penalties for giving false or misleading information to federal agencies. That applies when the law requires the information and it affects market analysis, and it covers both knowing and negligent conduct.
  • PBMs would have to send yearly reports to the FTC and HHS. The reports must cover price spreads, pharmacy fees and clawbacks, formulary tier changes that raise costs, and differences in how PBM-owned and other pharmacies are treated.

How Modern Action helps you take action on S. 526

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 526

What is S. 526?
PBMs would face new limits on hidden drug pricing, clawbacks, and some payment cuts to pharmacies. They would have to file yearly reports, and the Federal Trade Commission could impose steep penalties. Workers and contractors who report violations would get strong legal protection.
How do I support or oppose S. 526?
Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
Who should I contact about S. 526?
Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
Can Modern Action explain S. 526 before I act?
Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.

Keep acting on Modern Action

More ways to act on this issue

Compare the broader issue and related bills without leaving Modern Action.

Related issues

  • Contact your reps on Pharmacy benefit manager (PBM) rebate reformReforming PBM rebate practices to ensure that savings are passed on to consumers.

Related bills

  • Take action on S. 3549: PBM FAIR Act
  • Take action on H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]